Copyright © 2000 by the European Society of Cardiology.
Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality
a Medical Department, Central Hospital of Akershus, Nordbyhagen, Norway
b Institute for Informatics, University of Oslo, Norway
c Medical Department, Section of Cardiology, National Hospital, University of Oslo, Norway
d Institute for Medical Research, National Hospital, University of Oslo, Norway
revised February 1, 2000; accepted February 2, 2000
Abstract
Aims Since atherosclerosis is a chronic inflammation and the erythrocyte sedimentation rate is an appropriate test for monitoring chronic inflammatory responses, we wanted to investigate whether the erythrocyte sedimentation rate might carry prognostic information on the risk of sustaining coronary heart disease events.
Method The erythrocyte sedimentation rate was determined in 2014 apparently healthy men aged 40–60 years during an extensive cardiovascular survey in 1972–75, and the test was repeated in an identical follow-up examination 7 years later. Cause-specific mortality and rates of non-fatal myocardial infarction were followed for 23 years.
Results The erythrocyte sedimentation rate was strongly correlated with age, haemoglobin level, smoking status, total cholesterol level and systolic blood pressure. After adjusting for all these associations in multivariate Cox regression analyses, the erythrocyte sedimentation rate emerged as a strong short- and long-term predictor of coronary heart disease mortality, particularly in men who had developed angina pectoris and/or had a positive exercise ECG test at the second survey. Increases in non-coronary heart disease deaths and in non-fatal myocardial infarctions were only seen in the upper erythrocyte sedimentation rate range.
Conclusions The erythrocyte sedimentation rate is a strong predictor of coronary heart disease mortality, and appears to be a marker of aggressive forms of coronary heart disease. The erythrocyte sedimentation rate probably gives substantial information in addition to that given by fibrinogen on the risk of coronary heart disease death.
Key Words: Erythrocyte sedimentation rate, atherosclerosis, coronary heart disease mortality, non-fatal myocardial infarction, prediction
f1 Correspondence: Gunnar Erikssen, MD, Medical Department, Central Hospital of Akershus, N-1474 Nordbyhagen, Norway.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. R. de Rooij, G. Nijpels, P. M. Nilsson, J. J. Nolan, R. Gabriel, E. Bobbioni-Harsch, G. Mingrone, J. M. Dekker, and for the Relationship Between Insulin Sensitivity a Low-Grade Chronic Inflammation in the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) Population: Associations with insulin resistance and cardiometabolic risk profile Diabetes Care, July 1, 2009; 32(7): 1295 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Akay, Z. Canturk, E. Akin, C. Bal, and Z. Gulbas Aspirin-Resistance Frequency: A Prospective Study in 280 Healthy Turkish Volunteers Clinical and Applied Thrombosis/Hemostasis, February 1, 2009; 15(1): 98 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Akalin, O. Alatas, and O. Colak Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients Eur. J. Endocrinol., January 1, 2008; 158(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Elosua, B. Bartali, J. M. Ordovas, A. M. Corsi, F. Lauretani, L. Ferrucci, and on Behalf of the InCHIANTI Investigators Association Between Physical Activity, Physical Performance, and Inflammatory Biomarkers in an Elderly Population: The InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saevarsdottir, O. O. Oskarsson, T. Aspelund, G. Eiriksdottir, T. Vikingsdottir, V. Gudnason, and H. Valdimarsson Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk J. Exp. Med., January 3, 2005; 201(1): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Erikssen, J. Bodegard, J. V. Bjornholt, K. Liestol, D. S. Thelle, and J. Erikssen Exercise testing of healthy men in a new perspective: from diagnosis to prognosis Eur. Heart J., June 1, 2004; 25(11): 978 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh, J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D.O. Lowe, M. B. Pepys, and V. Gudnason C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease N. Engl. J. Med., April 1, 2004; 350(14): 1387 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Natali, A. L'Abbate, and E. Ferrannini Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality Eur. Heart J., April 1, 2003; 24(7): 639 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.J. Koch and C. Raschka Over-training syndrome as a model of a coronary inflammation process? Eur. Heart J., August 2, 2001; 22(16): 1512 - 1512. [PDF]
|
|
|
|
|
|
E. Rapaport Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease? Eur. Heart J., October 1, 2000; 21(19): 1567 - 1569. [PDF]
|
|